Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$181.58 - $368.0 $15.4 Million - $31.3 Million
-85,049 Reduced 72.69%
31,946 $5.89 Million
Q1 2022

Apr 26, 2022

BUY
$303.87 - $423.8 $3.28 Million - $4.58 Million
10,796 Added 10.17%
116,995 $40.9 Million
Q4 2021

Feb 07, 2022

BUY
$347.28 - $421.83 $7.37 Million - $8.95 Million
21,211 Added 24.96%
106,199 $40.4 Million
Q3 2021

Oct 18, 2021

BUY
$405.61 - $524.84 $872,467 - $1.13 Million
2,151 Added 2.6%
84,988 $34.5 Million
Q2 2021

Aug 02, 2021

BUY
$372.84 - $481.5 $313,185 - $404,460
840 Added 1.02%
82,837 $39.2 Million
Q1 2021

Apr 27, 2021

SELL
$361.28 - $504.76 $5.57 Million - $7.78 Million
-15,421 Reduced 15.83%
81,997 $31.5 Million
Q4 2020

Jan 22, 2021

SELL
$292.7 - $370.96 $6.73 Million - $8.53 Million
-23,005 Reduced 19.1%
97,418 $36 Million
Q3 2020

Oct 28, 2020

BUY
$268.51 - $400.74 $545,075 - $813,502
2,030 Added 1.71%
120,423 $37.2 Million
Q2 2020

Jul 16, 2020

SELL
$256.46 - $373.01 $9.28 Million - $13.5 Million
-36,182 Reduced 23.41%
118,393 $43.8 Million
Q1 2020

Apr 30, 2020

BUY
$209.2 - $335.53 $2.53 Million - $4.05 Million
12,075 Added 8.47%
154,575 $42.2 Million
Q4 2019

Jan 23, 2020

BUY
$288.29 - $335.49 $41.1 Million - $47.8 Million
142,500 New
142,500 $47.3 Million
Q4 2019

Jan 22, 2020

SELL
$288.29 - $335.49 $45.8 Million - $53.3 Million
-158,848 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$266.84 - $378.23 $1.45 Million - $2.05 Million
-5,418 Reduced 3.3%
158,848 $48.3 Million
Q2 2019

Jul 17, 2019

BUY
$300.59 - $368.15 $18.7 Million - $23 Million
62,360 Added 61.19%
164,266 $60.5 Million
Q1 2019

Apr 18, 2019

BUY
$272.57 - $321.18 $27.8 Million - $32.7 Million
101,906 New
101,906 $31.7 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Waverton Investment Management LTD Portfolio

Follow Waverton Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.